Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Clinical trial NCT07227246 · RECRUITING

Trial details

NCT number: NCT07227246
Sponsor: Joseph Broderick, MD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Intracerebral Hemorrhage

Start date: 2025-05-06
Primary completion: 2029-01-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.